Sept 30 (Reuters) - Adverum Biotechnologies Inc
:
* ADVERUM BIOTECHNOLOGIES PRESENTS ANATOMICAL IMPROVEMENTS IN INTRARETINAL AND SUBRETINAL FLUID AFTER A SINGLE IVT INJECTION OF IXO-VEC (ADVM-022) IN THE OPTIC STUDY IN WET AMD
Source text for Eikon: Further company coverage: